Clinical Trials Logo

Lymphoblastic Lymphoma clinical trials

View clinical trials related to Lymphoblastic Lymphoma.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT03592576 No longer available - Myelofibrosis Clinical Trials

Expanded Access to Navitoclax

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to navitoclax prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.